BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34854867)

  • 1. Mass spectrometric detection of KRAS protein mutations using molecular imprinting.
    Norman RL; Singh R; Muskett FW; Parrott EL; Rufini A; Langridge JI; Runau F; Dennison A; Shaw JA; Piletska E; Canfarotta F; Ng LL; Piletsky S; Jones DJL
    Nanoscale; 2021 Dec; 13(48):20401-20411. PubMed ID: 34854867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the protein corona take over the selectivity of molecularly imprinted nanoparticles? The biological challenges to recognition.
    Capriotti A; Piovesana S; Zenezini Chiozzi R; Montone CM; Bossi AM; Laganà A
    J Proteomics; 2020 May; 219():103736. PubMed ID: 32198073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope approach in molecular imprinting of antibodies.
    Moczko E; Guerreiro A; Cáceres C; Piletska E; Sellergren B; Piletsky SA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():1-6. PubMed ID: 31176265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of EGFR Activity by Molecularly Imprinted Polymer Nanoparticles Targeting Intracellular Epitopes.
    Piletsky SS; Baidyuk E; Piletska EV; Lezina L; Shevchenko K; Jones DJL; Cao TH; Singh R; Spivey AC; Aboagye EO; Piletsky SA; Barlev NA
    Nano Lett; 2023 Nov; 23(21):9677-9682. PubMed ID: 37902816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Recognition of Human Vascular Endothelial Growth Factor by Molecularly Imprinted Polymers.
    Cecchini A; Raffa V; Canfarotta F; Signore G; Piletsky S; MacDonald MP; Cuschieri A
    Nano Lett; 2017 Apr; 17(4):2307-2312. PubMed ID: 28350162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct replacement of antibodies with molecularly imprinted polymer nanoparticles in ELISA--development of a novel assay for vancomycin.
    Chianella I; Guerreiro A; Moczko E; Caygill JS; Piletska EV; De Vargas Sansalvador IM; Whitcombe MJ; Piletsky SA
    Anal Chem; 2013 Sep; 85(17):8462-8. PubMed ID: 23947402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecularly Imprinted Polymer Nanoparticles Enable Rapid, Reliable, and Robust Point-of-Care Thermal Detection of SARS-CoV-2.
    McClements J; Bar L; Singla P; Canfarotta F; Thomson A; Czulak J; Johnson RE; Crapnell RD; Banks CE; Payne B; Seyedin S; Losada-Pérez P; Peeters M
    ACS Sens; 2022 Apr; 7(4):1122-1131. PubMed ID: 35416035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does size matter? Study of performance of pseudo-ELISAs based on molecularly imprinted polymer nanoparticles prepared for analytes of different sizes.
    Cáceres C; Canfarotta F; Chianella I; Pereira E; Moczko E; Esen C; Guerreiro A; Piletska E; Whitcombe MJ; Piletsky SA
    Analyst; 2016 Feb; 141(4):1405-12. PubMed ID: 26796951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.
    Wen YS; Cai L; Zhang XW; Zhu JF; Zhang ZC; Shao JY; Zhang LJ
    Medicine (Baltimore); 2014 Dec; 93(29):e296. PubMed ID: 25546673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
    Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecularly Imprinted Nanoparticles (NanoMIPs) Selective for Proteins: Optimization of a Protocol for Solid-Phase Synthesis Using Automatic Chemical Reactor.
    Cáceres C; Moczko E; Basozabal I; Guerreiro A; Piletsky S
    Polymers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer.
    Reggiani Bonetti L; Barresi V; Bettelli S; Caprera C; Manfredini S; Maiorana A
    Hum Pathol; 2017 Apr; 62():91-98. PubMed ID: 28025078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of acetylcholinesterase activity using molecularly imprinted polymer nanoparticles.
    Piletsky SA; Bedwell TS; Paoletti R; Karim K; Canfarotta F; Norman R; Jones DJL; Turner NW; Piletska EV
    J Mater Chem B; 2022 Sep; 10(35):6732-6741. PubMed ID: 35355036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of KRAS mutations, persistent organic pollutants, and trace elements on survival from pancreatic ductal adenocarcinoma.
    Porta M; Pumarega J; Amaral AFS; Genkinger JM; Camargo J; Mucci L; Alguacil J; Gasull M; Zhang X; Morales E; Iglesias M; Ogino S; Engel LS;
    Environ Res; 2020 Nov; 190():109781. PubMed ID: 32791343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecularly imprinted polymer nanoparticle-based assay (MINA): application for fumonisin B1 determination.
    Munawar H; Smolinska-Kempisty K; Cruz AG; Canfarotta F; Piletska E; Karim K; Piletsky SA
    Analyst; 2018 Jul; 143(14):3481-3488. PubMed ID: 29923557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecularly Imprinted Nanoparticles for Biomedical Applications.
    Zhang H
    Adv Mater; 2020 Jan; 32(3):e1806328. PubMed ID: 31090976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The measurement of KRAS G12 mutants using multiplexed selected reaction monitoring and ion mobility mass spectrometry.
    Norman RL; Singh R; Langridge JI; Ng LL; Jones DJL
    Rapid Commun Mass Spectrom; 2020 Sep; 34 Suppl 4(Suppl 4):e8657. PubMed ID: 31800120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology.
    Perez K; Walsh R; Brilliant K; Noble L; Yakirevich E; Breese V; Jackson C; Chatterjee D; Pricolo V; Roth L; Shah N; Cataldo T; Safran H; Hixson D; Quesenberry P
    Exp Mol Pathol; 2013 Aug; 95(1):74-82. PubMed ID: 23528430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of Cyt c interactions with HSP27 and Bcl-xL using molecularly imprinted polymers (MIPs) coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based targeted proteomics.
    Zhang W; Zhang T; Chen Y
    J Proteomics; 2019 Feb; 192():188-195. PubMed ID: 30237093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacement of Antibodies in Pseudo-ELISAs: Molecularly Imprinted Nanoparticles for Vancomycin Detection.
    Canfarotta F; Smolinska-Kempisty K; Piletsky S
    Methods Mol Biol; 2017; 1575():389-398. PubMed ID: 28255895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.